Validation of a Tissue Microarray to Study Differential Protein Expression in Inflammatory and Non-Inflammatory Breast Cancer
dc.contributor.author | Van der Auwera, I. | en_US |
dc.contributor.author | Merajver, Sofia D. | en_US |
dc.contributor.author | Colpaert, C. G. | en_US |
dc.contributor.author | Van den Eynden, G. G. | en_US |
dc.contributor.author | Van Laere, S. | en_US |
dc.contributor.author | van Dam, P. | en_US |
dc.contributor.author | Kleer, Celina G. | en_US |
dc.contributor.author | Harris, Adrian | en_US |
dc.contributor.author | Van Marck, E. A. | en_US |
dc.contributor.author | Dirix, Luc Y. | en_US |
dc.contributor.author | Vermeulen, Peter B. | en_US |
dc.date.accessioned | 2006-09-11T14:27:42Z | |
dc.date.available | 2006-09-11T14:27:42Z | |
dc.date.issued | 2004-05 | en_US |
dc.identifier.citation | Van den Eynden, G.G.; Van der Auwera, I.; Van Laere, S.; Colpaert, C.G.; van Dam, P.; Merajver, S.; Kleer, C.G.; Harris, A.L.; Van Marck, E.A.; Dirix, L.Y.; Vermeulen, P.B.; (2004). "Validation of a Tissue Microarray to Study Differential Protein Expression in Inflammatory and Non-Inflammatory Breast Cancer." Breast Cancer Research and Treatment 85(1): 13-22. <http://hdl.handle.net/2027.42/44222> | en_US |
dc.identifier.issn | 0167-6806 | en_US |
dc.identifier.issn | 1573-7217 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/44222 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15039594&dopt=citation | en_US |
dc.description.abstract | Aims. Inflammatory breast cancer (IBC) is an aggressive subtype of breast cancer with poor prognosis. The mechanisms responsible for the aggressive clinical evolution are incompletely understood. We constructed a tissue microarray (TMA) and validated its use in translational IBC research. Differential expression of proteins that might play a role in causing the IBC phenotype was studied. | en_US |
dc.format.extent | 276811 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Kluwer Academic Publishers; Springer Science+Business Media | en_US |
dc.subject.other | Tissue Microarray | en_US |
dc.subject.other | Inflammatory Breast Cancer | en_US |
dc.subject.other | Epidermal Growth Factor Receptor | en_US |
dc.subject.other | Oncology | en_US |
dc.subject.other | Medicine & Public Health | en_US |
dc.subject.other | Carbonic Anhydrase IX | en_US |
dc.subject.other | Differential Protein Expression | en_US |
dc.subject.other | E-Cadherin | en_US |
dc.subject.other | Estrogen Receptor | en_US |
dc.subject.other | HER2/Neu | en_US |
dc.subject.other | Immunohistochemistry | en_US |
dc.subject.other | P53 | en_US |
dc.subject.other | Progesterone Receptor | en_US |
dc.subject.other | RhoC GTPase | en_US |
dc.title | Validation of a Tissue Microarray to Study Differential Protein Expression in Inflammatory and Non-Inflammatory Breast Cancer | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Ophthalmology | en_US |
dc.subject.hlbsecondlevel | Otolaryngology | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pathology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, University of Michigan, USA | en_US |
dc.contributor.affiliationother | Translational Cancer Research Group, Laboratory of Pathology, University Hospital Antwerp, University of Antwerp, Edegem; Translational Cancer Research Group, Oncology Centre, General Hospital Sint-Augustinus, Wilrijk, Belgium | en_US |
dc.contributor.affiliationother | Translational Cancer Research Group, Laboratory of Pathology, University Hospital Antwerp, University of Antwerp, Edegem; Translational Cancer Research Group, Oncology Centre, General Hospital Sint-Augustinus, Wilrijk, Belgium | en_US |
dc.contributor.affiliationother | Translational Cancer Research Group, Laboratory of Pathology, University Hospital Antwerp, University of Antwerp, Edegem; Translational Cancer Research Group, Oncology Centre, General Hospital Sint-Augustinus, Wilrijk, Belgium | en_US |
dc.contributor.affiliationother | Translational Cancer Research Group, Laboratory of Pathology, University Hospital Antwerp, University of Antwerp, Edegem; Translational Cancer Research Group, Oncology Centre, General Hospital Sint-Augustinus, Wilrijk, Belgium | en_US |
dc.contributor.affiliationother | Translational Cancer Research Group, Laboratory of Pathology, University Hospital Antwerp, University of Antwerp, Edegem; Translational Cancer Research Group, Oncology Centre, General Hospital Sint-Augustinus, Wilrijk, Belgium | en_US |
dc.contributor.affiliationother | Translational Cancer Research Group, Laboratory of Pathology, University Hospital Antwerp, University of Antwerp, Edegem; Translational Cancer Research Group, Oncology Centre, General Hospital Sint-Augustinus, Wilrijk, Belgium | en_US |
dc.contributor.affiliationother | Translational Cancer Research Group, Laboratory of Pathology, University Hospital Antwerp, University of Antwerp, Edegem; Translational Cancer Research Group, Oncology Centre, General Hospital Sint-Augustinus, Wilrijk, Belgium | en_US |
dc.contributor.affiliationother | Cancer Research UK Growth Factor Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK | en_US |
dc.contributor.affiliationother | Translational Cancer Research Group, Laboratory of Pathology, University Hospital Antwerp, University of Antwerp, Edegem; Translational Cancer Research Group, Oncology Centre, General Hospital Sint-Augustinus, Wilrijk, Belgium | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 15039594 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/44222/1/10549_2004_Article_5256693.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1023/B:BREA.0000021028.33926.a8 | en_US |
dc.identifier.source | Breast Cancer Research and Treatment | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.